Open access · CC-BY
via OpenAlex
Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
Connor Bargar, Wen Wang, Steven A. Gunzler, Alexandra N. LeFevre, Zerui Wang, Alan Jay Lerner, Neena Singh, Curtis M. Tatsuoka, Brian Stephen Appleby, Xiongwei Zhu, Rong Xu, Vahram H. Haroutunian, Wen‐Quan Zou, Jiyan Ma, Shu G. Chen
Acta Neuropathologica Communications · 2021 · ▲ 202 citations
Abstract
Abstract Definitive diagnosis of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) relies on postmortem finding of disease-associated alpha-synuclein (αSyn D ) as misfolded protein aggregates in the central nervous system (CNS). The recent development of the real-time quaking induced conversion (RT-QuIC) assay for ultrasensitive detection of αSyn D aggregates has revitalized the diagnostic values of clinically accessible biospecimens, including cerebrospinal fluid (CSF) and peripheral tissues. However, the current αSyn RT-QuIC assay platforms vary widely and are thus challenging to implement and standardize the measurements of αSyn D across a wide range of biospecimens and in different laboratories. We have streamlined αSyn RT-QuIC assay based on a second generation assay platform that was assembled entirely with commercial reagents. The streamlined RT-QuIC method consisted of a simplified protocol requiring minimal hands-on time, and allowing for a uniform analysis of αSyn D in different types of biospecimens from PD and DLB. Ultrasensitive and specific RT-QuIC detection of αSyn D aggregates was achieved in million-fold diluted brain homogenates and in nanoliters of CSF from PD and DLB cases but not from controls. Comparative analysis revealed higher seeding activity of αSyn D in DLB than PD in both brain homogenates and CSF. Our assay was further validated with CSF samples of 214 neuropathologically confirmed cases from tissue repositories (88 PD, 58 DLB, and 68 controls), yielding a sensitivity of 98% and a specificity of 100%. Finally, a single RT-QuIC assay protocol was employed uniformly to detect seeding activity of αSyn D in PD samples across different types of tissues including the brain, skin, salivary gland, and colon. We anticipate that our streamlined protocol will enable interested laboratories to easily and rapidly implement the αSyn RT-QuIC assay for various clinical specimens from PD and DLB. The utilization of commercial products for all assay components will improve the robustness and standardization of the RT-QuIC assay for diagnostic applications across different sites. Due to ultralow sample consumption, the ultrasensitive RT-QuIC assay will facilitate efficient use and sharing of scarce resources of biospecimens. Our streamlined RT-QuIC assay is suitable to track the distribution of αSyn D in CNS and peripheral tissues of affected patients. The ongoing evaluation of RT-QuIC assay of αSyn D as a potential biomarker for PD and DLB in clinically accessible biospecimens has broad implications for understanding disease pathogenesis, improving early and differential diagnosis, and monitoring therapeutic efficacies in clinical trials.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s40478-021-01175-w
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Bargar, C., Wang, W., Gunzler, S.A., LeFevre, A.N., Wang, Z., Lerner, A.J., Singh, N., Tatsuoka, C.M., Appleby, B.S., Zhu, X., Xu, R., Haroutunian, V.H., Zou, W., Ma, J., & Chen, S.G. (2021). Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies. <em>Acta Neuropathologica Communications</em>. https://doi.org/10.1186/s40478-021-01175-w
Vancouver
Bargar C, Wang W, Gunzler SA, LeFevre AN, Wang Z, Lerner AJ, et al. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies. Acta Neuropathologica Communications. 2021. doi:10.1186/s40478-021-01175-w.
BibTeX
@article{connor2021Stream,
title = {Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies},
author = {Connor Bargar and Wen Wang and Steven A. Gunzler and Alexandra N. LeFevre and Zerui Wang and Alan Jay Lerner and Neena Singh and Curtis M. Tatsuoka and Brian Stephen Appleby and Xiongwei Zhu and Rong Xu and Vahram H. Haroutunian and Wen‐Quan Zou and Jiyan Ma and Shu G. Chen},
journal = {Acta Neuropathologica Communications},
year = {2021},
doi = {10.1186/s40478-021-01175-w},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Parkinson's disease 2026
Open access · OA
Detection of α-synuclein seeding activity in tear fluid as a candidate biomarker for Parkinson's disease.
Movement Disorders 2019
Open access · CC-BY
Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's disease
BMC Cancer 2008
Open access · CC-BY
Amplification of HER2 is a marker for global genomic instability
Antioxidants 2021
Open access · CC-BY
Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
Acta Neuropathologica Communications 2021
Open access · CC-BY
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
Experimental gerontology 2026
Citation only